Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Prosperini

Showing results (21-30 of 182) with videos related to

Pageof 19
Sort By:
The Journal of Headache and Pain|April 12, 2011
Efficacy and tolerability of pregabalin as preventive treatment for migraine: a 3-month follow-up studyRaffaella Pizzolato, Veronica Villani, Luca Prosperini, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 31, 2024
Disability patterns in multiple sclerosis: A meta-analysis on RAW and PIRA in the real-world contextLuca Prosperini, Serena Ruggieri, Shalom Haggiag, et al.
Journal of Neurology|January 13, 2015
Far transfer effect associated with video game balance training in multiple sclerosis: from balance to cognition?Luca Prosperini, Nikolaos Petsas, Emilia Sbardella, et al.
Journal of Neurology|February 8, 2019
Non-alcoholic Wernicke encephalopathy presenting as bilateral hearing loss: a case reportLuca Prosperini, Alessandro Stasolla, Gabriella Grieco, et al.
Multiple Sclerosis and Related Disorders|December 7, 2016
Extratemporal herpes encephalitis during natalizumab treatment: A case reportShalom Haggiag, Luca Prosperini, Simonetta Galgani, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 12, 2017
Single-blind, randomized, pilot study combining shiatsu and amitriptyline in refractory primary headachesVeronica Villani, Luca Prosperini, Fulvio Palombini, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 1, 2023
Dimethyl Fumarate or Teriflunomide for Relapsing-Remitting Multiple Sclerosis: A Meta-analysis of Post-marketing StudiesLuca Prosperini, Shalom Haggiag, Serena Ruggieri, et al.
CNS Drugs|September 23, 2023
Stopping Disease-Modifying Treatments in Multiple Sclerosis: A Systematic Review and Meta-Analysis of Real-World StudiesLuca Prosperini, Shalom Haggiag, Serena Ruggieri, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 26, 2020
Age-related adverse events of disease-modifying treatments for multiple sclerosis: A meta-regressionLuca Prosperini, Shalom Haggiag, Carla Tortorella, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 15, 2010
Observations during an elective interruption of natalizumab treatment: a post-marketing studyGiovanna Borriello, Luca Prosperini, Fabiana Marinelli, et al.
Pageof 19

Showing results (21-30 of 182) with videos related to

Sort By:
Pageof 19
The Journal of Headache and Pain|April 12, 2011
Efficacy and tolerability of pregabalin as preventive treatment for migraine: a 3-month follow-up studyRaffaella Pizzolato, Veronica Villani, Luca Prosperini, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 31, 2024
Disability patterns in multiple sclerosis: A meta-analysis on RAW and PIRA in the real-world contextLuca Prosperini, Serena Ruggieri, Shalom Haggiag, et al.
Journal of Neurology|January 13, 2015
Far transfer effect associated with video game balance training in multiple sclerosis: from balance to cognition?Luca Prosperini, Nikolaos Petsas, Emilia Sbardella, et al.
Journal of Neurology|February 8, 2019
Non-alcoholic Wernicke encephalopathy presenting as bilateral hearing loss: a case reportLuca Prosperini, Alessandro Stasolla, Gabriella Grieco, et al.
Multiple Sclerosis and Related Disorders|December 7, 2016
Extratemporal herpes encephalitis during natalizumab treatment: A case reportShalom Haggiag, Luca Prosperini, Simonetta Galgani, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 12, 2017
Single-blind, randomized, pilot study combining shiatsu and amitriptyline in refractory primary headachesVeronica Villani, Luca Prosperini, Fulvio Palombini, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 1, 2023
Dimethyl Fumarate or Teriflunomide for Relapsing-Remitting Multiple Sclerosis: A Meta-analysis of Post-marketing StudiesLuca Prosperini, Shalom Haggiag, Serena Ruggieri, et al.
CNS Drugs|September 23, 2023
Stopping Disease-Modifying Treatments in Multiple Sclerosis: A Systematic Review and Meta-Analysis of Real-World StudiesLuca Prosperini, Shalom Haggiag, Serena Ruggieri, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 26, 2020
Age-related adverse events of disease-modifying treatments for multiple sclerosis: A meta-regressionLuca Prosperini, Shalom Haggiag, Carla Tortorella, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 15, 2010
Observations during an elective interruption of natalizumab treatment: a post-marketing studyGiovanna Borriello, Luca Prosperini, Fabiana Marinelli, et al.
Pageof 19